$VINE
Fresh Vine Wine, Inc. Stock $vine

$vine Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024068975 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue	$63.21K	$70.48K	$239.5K
YoY Change	-92.55%	-78.65%	-36.29%
Cost Of Revenue	$65.05K	$114.2K	$780.6K
YoY Change	-92.69%	-95.1%	55.7%
Gross Profit	$152.6K	-$43.68K	-$541.2K
YoY Change	-464.44%	-97.82%	331.4%
Gross Profit Margin	241.49%	-61.97%	-225.97%
Selling, General & Admin	$460.0K	$834.3K	$1.511M
YoY Change	-59.7%	-57.66%	-58.96%
% of Gross Profit	301.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change
% of Gross Profit
Operating Expenses	$460.0K	$834.3K	$1.511M
YoY Change	-59.7%	-57.66%	-58.96%
Operating Profit	-$309.0K	-$879.6K	-$2.052M
YoY Change	-85.49%	-80.11%	-46.09%
Interest Expense	$6.322K
YoY Change
% of Operating Profit
Other Income/Expense, Net			$0.00
YoY Change			-100.0%
Pretax Income	-$315.3K	-$879.6K	-$2.052M
YoY Change	-85.2%	-80.11%	-45.96%
Income Tax
% Of Pretax Income
Net Earnings	-$315.3K	-$879.6K	-$2.094M
YoY Change	-85.2%	-80.11%	-44.85%
Net Earnings / Revenue	-498.81%	-1247.9%	-874.44%
Basic Earnings Per Share	-$0.02	-$0.06
Diluted Earnings Per Share	-$0.02	-$0.06	-$0.13
COMMON SHARES
Basic Shares Outstanding	15.98M shares	15.98M shares	15.98M shares
Diluted Shares Outstanding	15.98M shares	15.98M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$72.03K	$144.8K	$236.3K
YoY Change	-90.52%	-69.63%	-88.64%
Cash & Equivalents	$122.1K	$145.0K	$236.0K
Short-Term Investments
Other Short-Term Assets	$131.6K	$72.96K	$142.9K
YoY Change	-80.47%	-93.88%	-86.12%
Inventory	$232.8K	$101.5K	$337.9K
Prepaid Expenses	$81.59K	$22.92K	$9.871K
Receivables	$45.28K	$37.51K	$172.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$481.8K	$356.7K	$889.3K
YoY Change	-81.52%	-89.19%	-88.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$500.0K	$500.0K	$500.0K
YoY Change
Other Assets			$0.00
YoY Change			-100.0%
Total Long-Term Assets	$500.0K	$500.0K	$500.0K
YoY Change		-4.15%	-26.27%
TOTAL ASSETS
Total Short-Term Assets	$481.8K	$356.7K	$889.3K
Total Long-Term Assets	$500.0K	$500.0K	$500.0K
Total Assets	$981.8K	$856.7K	$1.389M
YoY Change	-62.34%	-77.57%	-83.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.157M	$1.113M	$509.3K
YoY Change	108.57%	65.22%	-13.56%
Accrued Expenses	$1.126M	$1.015M	$810.7K
YoY Change	69.17%	79.18%	91.69%
Deferred Revenue	$2.685K	$3.268K	$3.407K
YoY Change
Short-Term Debt	$27.50K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$175.0K
YoY Change
Total Short-Term Liabilities	$3.383M	$3.026M	$2.219M
YoY Change	120.9%	107.11%	-25.36%
LONG-TERM LIABILITIES
Long-Term Debt	$387.5K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$387.5K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.383M	$3.026M	$2.219M
Total Long-Term Liabilities	$387.5K	$0.00	$0.00
Total Liabilities	$3.383M	$3.026M	$2.219M
YoY Change	120.9%	107.11%	-25.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.99M	-$28.62M	-$26.50M
YoY Change	18.82%	28.63%	67.51%
Common Stock	$15.98K	$15.98K	$15.98K
YoY Change	0.0%	-6.12%	25.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.402M	-$2.169M	-$829.5K
YoY Change
Total Liabilities & Shareholders Equity	$981.8K	$856.7K	$1.389M
YoY Change	-62.34%	-77.57%	-83.82%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$315.3K	-$879.6K	-$2.094M
YoY Change	-85.2%	-80.11%	-44.85%
Depreciation, Depletion And Amortization			$0.00
YoY Change
Cash From Operating Activities	-$400.2K	-$613.8K	-$223.6K
YoY Change	9.12%	-71.14%	-82.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities			-$500.0K
YoY Change
Cash From Investing Activities			-$500.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$678.5K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	327.5K	699.7K	200.0K
YoY Change	-56.33%		-392.87%
NET CHANGE
Cash From Operating Activities	-400.2K	-613.8K	-223.6K
Cash From Investing Activities			-500.0K
Cash From Financing Activities	327.5K	699.7K	200.0K
Net Change In Cash	-72.73K	85.94K	-523.6K
YoY Change	-118.98%	-104.04%	-60.78%
FREE CASH FLOW
Cash From Operating Activities	-$400.2K	-$613.8K	-$223.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41147
	dei	Entity Registrant Name EntityRegistrantName	Fresh Vine Wine, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3905007
	dei	Entity Address Address Line1 EntityAddressAddressLine1	P.O. Box 78984
	dei	Entity Address City Or Town EntityAddressCityOrTown	Charlotte
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28271
	dei	City Area Code CityAreaCode	(855)
	dei	Local Phone Number LocalPhoneNumber	766-9463
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	VINE
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15976227	shares
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	144756	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	236340	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	50039	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37513	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	172101	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	101451	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	337873	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	22917	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	42943	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	356676	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	889257	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	500000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	500000	usd
CY2024Q2	us-gaap	Assets Assets	856676	usd
CY2023Q4	us-gaap	Assets Assets	1389257	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1112826	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	509337	usd
CY2024Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	585976	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	585976	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1014541	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	810723	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3268	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3407	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3025944	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2218776	usd
CY2024Q2	us-gaap	Liabilities Liabilities	3025944	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2218776	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15976227	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15976227	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15976227	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15976227	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	15976	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15976	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26439514	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25631255	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28624777	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26476760	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-2169268	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-829519	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	856676	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1389257	usd
CY2024Q2	us-gaap	Revenues Revenues	70484	usd
CY2023Q2	us-gaap	Revenues Revenues	330125	usd
	us-gaap	Revenues Revenues	175052	usd
	us-gaap	Revenues Revenues	738755	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	114160	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2329655	usd
	us-gaap	Cost Of Revenue CostOfRevenue	329976	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2741647	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-43676	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-1999530	usd
	us-gaap	Gross Profit GrossProfit	-154924	usd
	us-gaap	Gross Profit GrossProfit	-2002892	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	834267	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1970380	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1933748	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3643145	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1626	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	452427	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3251	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	788350	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-879569	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4422337	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2091923	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6434387	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	40	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	39	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1266	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-879569	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4422297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2091884	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6433121	usd
CY2024Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	26133	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	56133	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-905702	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4422297	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2148017	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6433121	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15976227	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16606442	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15976227	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14983854	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15976227	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16606442	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15976227	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14983854	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5613606	usd
CY2023Q1	vine	Stock Issued During Period Value Rights Offering Common Stock And Warrants Issued StockIssuedDuringPeriodValueRightsOfferingCommonStockAndWarrantsIssued	2546728	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	257672	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2010824	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6407182	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	374178	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4422297	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2359063	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-829519	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	90325	usd
CY2024Q1	vine	Accrued Preferred Dividends AccruedPreferredDividends	0.12	pure
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	30000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1625	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1212315	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1979884	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	714692	usd
CY2024Q2	vine	Accrued Preferred Dividends AccruedPreferredDividends	0.12	pure
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	26133	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1626	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-879569	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-2169268	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2091884	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6433121	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3251	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	788350	usd
	us-gaap	Inventory Write Down InventoryWriteDown	154483	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1732500	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	37733	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-134588	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-125975	usd
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-804907	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-81939	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-467691	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-20026	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	231145	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	603489	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	84327	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-420413	usd
	vine	Increase Decrease In Settlement Payable IncreaseDecreaseInSettlementPayable	-1250000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	147685	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	143287	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-60000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-139	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-8711	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-946562	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4218620	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	15000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	805017	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	2615014	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	805017	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2615014	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-141545	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1603606	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	336340	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2080335	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194795	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	476729	usd
	vine	Accrued Dividends AccruedDividends	56133	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4200000	usd
CY2024Q2	vine	Working Capital WorkingCapital	2700000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	50000	usd
	vine	Gross Proceeds From Sale Of Preferred Stock GrossProceedsFromSaleOfPreferredStock	914000	usd
CY2023Q4	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	1000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration:underline">Accounting Estimates</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management uses estimates and assumptions in preparing these financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include allowance for doubtful accounts, allowance for inventory obsolescence, equity-based compensation for employees and non-employees, and the valuation of deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	154000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	112000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.50	pure
CY2024Q2	us-gaap	Advertising Expense AdvertisingExpense	182000	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	562000	usd
	us-gaap	Advertising Expense AdvertisingExpense	327000	usd
	us-gaap	Advertising Expense AdvertisingExpense	1200000	usd
CY2023Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	4000000	usd
	us-gaap	Stockholders Equity Other StockholdersEquityOther	2200000	usd
CY2023Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	2000000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-879569	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4422297	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2091884	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6433121	usd
CY2024Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	26133	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	56133	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-905702	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4422297	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2148017	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6433121	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15976227	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16606442	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15976227	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14983854	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15976227	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16606442	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15976227	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14983854	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17058862	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4826446	shares
CY2024Q2	us-gaap	Inventory Write Down InventoryWriteDown	44000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1700000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	101451	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	337873	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	154000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	112000	usd
CY2023Q4	vine	Prepaid Marketing Expenses Current PrepaidMarketingExpensesCurrent	9871	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	22917	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	33072	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	22917	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	42943	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	500000	usd
CY2023Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	50000	shares
CY2024Q2	vine	Sponsorship Agreements Current SponsorshipAgreementsCurrent	832660	usd
CY2023Q4	vine	Sponsorship Agreements Current SponsorshipAgreementsCurrent	608818	usd
CY2024Q2	vine	Accrued Credit Card Charges Current AccruedCreditCardChargesCurrent	3569	usd
CY2023Q4	vine	Accrued Credit Card Charges Current AccruedCreditCardChargesCurrent	7275	usd
CY2024Q2	vine	Stock Dividends StockDividends	98000	usd
CY2023Q4	vine	Stock Dividends StockDividends	41867	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	48418	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	125704	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31894	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27059	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1014541	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	810723	usd
CY2024Q2	vine	Expenses Related To Sponsorship Agreements ExpensesRelatedToSponsorshipAgreements	172000	usd
CY2023Q2	vine	Expenses Related To Sponsorship Agreements ExpensesRelatedToSponsorshipAgreements	124000	usd
	vine	Expenses Related To Sponsorship Agreements ExpensesRelatedToSponsorshipAgreements	296000	usd
	vine	Expenses Related To Sponsorship Agreements ExpensesRelatedToSponsorshipAgreements	177000	usd
CY2023Q2	us-gaap	Temporary Equity Shares Subscribed But Unissued TemporaryEquitySharesSubscribedButUnissued	6366129	shares
CY2023Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.25
CY2023Q1	vine	Stockholder Received Subscription Rights StockholderReceivedSubscriptionRights	0.5
CY2023Q1	vine	Stockholders Subscription Per Share StockholdersSubscriptionPerShare	1
CY2023Q1	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	3140000	usd
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	2600000	usd
	vine	Sale Leaseback Transaction Gross Proceed Investing Activities SaleLeasebackTransactionGrossProceedInvestingActivities	3930000	usd
CY2024Q2	vine	Aggregate Share Purchase AggregateSharePurchase	10000	shares
CY2023Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4000	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2000	shares
CY2024Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.05
	vine	Capital Or Surplus Of Percentage CapitalOrSurplusOfPercentage	1.50	pure
	vine	Stock Issued And Outstanding StockIssuedAndOutstanding	0.50	pure
	vine	Price Per Share Of Redemption Percentage PricePerShareOfRedemptionPercentage	2	pure
	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.12	pure
	vine	Closing Price Of Common Stock As Execution And Delivery ClosingPriceOfCommonStockAsExecutionAndDelivery	0.47
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	98000	usd
CY2023	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	41867	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	9135	shares
	vine	Gross Proceeds GrossProceeds	913500	usd
	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.45
	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	0.05
	vine	Per Share Percentage PerSharePercentage	2	pure
	vine	Percentage Of Gross Proceed PercentageOfGrossProceed	0.08	pure
CY2024Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	300000	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.5
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	970000	shares
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1030000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	25000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	25000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	446559	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.88
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y29D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	446559	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.88
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M29D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	71559	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y2M1D
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3007	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.75	pure
	vine	Net Expense Relating To Agreements NetExpenseRelatingToAgreements	0	usd
	vine	Net Expense Relating To Agreements NetExpenseRelatingToAgreements	240000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable		usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities		usd
	vine	Increase Decrease In Settlement Payable IncreaseDecreaseInSettlementPayable		usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	vine	Accrued Dividends AccruedDividends		usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2024Q2	vine	Prepaid Marketing Expenses Current PrepaidMarketingExpensesCurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001880343

Files In Submission

Name	View Source	Status
0001213900-24-068975-index-headers.html	Edgar Link	pending
0001213900-24-068975-index.html	Edgar Link	pending
0001213900-24-068975.txt	Edgar Link	pending
0001213900-24-068975-xbrl.zip	Edgar Link	pending
ea0211166-10q_freshvine.htm	Edgar Link	pending
ea021116601ex31-1_freshvine.htm	Edgar Link	pending
ea021116601ex31-2_freshvine.htm	Edgar Link	pending
ea021116601ex32-1_freshvine.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vine-20240630.xsd	Edgar Link	pending
vine-20240630_def.xml	Edgar Link	unprocessable
vine-20240630_lab.xml	Edgar Link	unprocessable
vine-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
vine-20240630_cal.xml	Edgar Link	unprocessable
ea0211166-10q_freshvine_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VINE
Fresh Vine Wine, Inc. Stock $vine

2024 Q3 Form 10-Q Financial Statement

#000121390024068975 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VINE Fresh Vine Wine, Inc. Stock $vine

2024 Q3 Form 10-Q Financial Statement

#000121390024068975 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VINE
Fresh Vine Wine, Inc. Stock $vine